Tandem Investment Advisors Inc. raised its stake in Genpact Limited (NYSE:G - Free Report) by 390.5% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 2,129,915 shares of the business services provider's stock after purchasing an additional 1,695,706 shares during the period. Genpact accounts for approximately 3.5% of Tandem Investment Advisors Inc.'s holdings, making the stock its 11th biggest holding. Tandem Investment Advisors Inc. owned 1.21% of Genpact worth $91,480,000 at the end of the most recent reporting period.
Other institutional investors have also modified their holdings of the company. Creative Planning raised its position in shares of Genpact by 19.4% during the 3rd quarter. Creative Planning now owns 30,590 shares of the business services provider's stock valued at $1,199,000 after acquiring an additional 4,976 shares in the last quarter. Sequoia Financial Advisors LLC raised its stake in Genpact by 5.8% during the third quarter. Sequoia Financial Advisors LLC now owns 23,315 shares of the business services provider's stock worth $914,000 after acquiring an additional 1,281 shares during the period. Signaturefd LLC lifted its holdings in Genpact by 10.4% in the third quarter. Signaturefd LLC now owns 17,069 shares of the business services provider's stock worth $669,000 after acquiring an additional 1,611 shares during the last quarter. Lecap Asset Management Ltd. boosted its stake in Genpact by 2.1% in the third quarter. Lecap Asset Management Ltd. now owns 18,059 shares of the business services provider's stock valued at $708,000 after acquiring an additional 364 shares during the period. Finally, Greenleaf Trust bought a new position in shares of Genpact during the third quarter valued at approximately $210,000. Institutional investors and hedge funds own 96.03% of the company's stock.
Analysts Set New Price Targets
Several analysts recently issued reports on the company. Needham & Company LLC raised their price target on Genpact from $55.00 to $65.00 and gave the stock a "buy" rating in a report on Friday, February 7th. Robert W. Baird increased their target price on Genpact from $44.00 to $48.00 and gave the stock a "neutral" rating in a research report on Friday, November 8th. Jefferies Financial Group raised shares of Genpact from a "hold" rating to a "buy" rating and boosted their price target for the company from $44.00 to $55.00 in a report on Tuesday, January 21st. TD Cowen raised shares of Genpact from a "hold" rating to a "buy" rating and increased their price objective for the stock from $45.00 to $60.00 in a report on Friday, February 7th. Finally, Mizuho lifted their price objective on shares of Genpact from $45.00 to $55.00 and gave the company a "neutral" rating in a research report on Monday, February 10th. Six research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat.com, Genpact presently has a consensus rating of "Hold" and a consensus price target of $48.44.
View Our Latest Stock Report on Genpact
Genpact Price Performance
G stock traded down $0.01 during trading on Tuesday, hitting $52.50. The company had a trading volume of 471,924 shares, compared to its average volume of 1,493,665. The business has a 50 day moving average of $47.17 and a 200 day moving average of $43.03. The firm has a market capitalization of $9.26 billion, a price-to-earnings ratio of 18.48, a P/E/G ratio of 1.84 and a beta of 1.20. The company has a current ratio of 2.16, a quick ratio of 1.85 and a debt-to-equity ratio of 0.50. Genpact Limited has a fifty-two week low of $30.23 and a fifty-two week high of $56.76.
Genpact (NYSE:G - Get Free Report) last issued its quarterly earnings results on Thursday, February 6th. The business services provider reported $0.82 earnings per share for the quarter, missing analysts' consensus estimates of $0.86 by ($0.04). Genpact had a return on equity of 22.50% and a net margin of 10.77%. As a group, research analysts predict that Genpact Limited will post 3.21 earnings per share for the current year.
Genpact Increases Dividend
The company also recently declared a quarterly dividend, which will be paid on Wednesday, March 26th. Shareholders of record on Tuesday, March 11th will be paid a dividend of $0.17 per share. This is a positive change from Genpact's previous quarterly dividend of $0.15. This represents a $0.68 dividend on an annualized basis and a yield of 1.30%. The ex-dividend date of this dividend is Tuesday, March 11th. Genpact's dividend payout ratio (DPR) is presently 23.94%.
Insider Activity
In related news, CEO Balkrishan Kalra sold 13,600 shares of the business's stock in a transaction that occurred on Friday, December 13th. The shares were sold at an average price of $44.60, for a total value of $606,560.00. Following the sale, the chief executive officer now directly owns 267,404 shares in the company, valued at $11,926,218.40. The trade was a 4.84 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, SVP Piyush Mehta sold 12,000 shares of the firm's stock in a transaction that occurred on Friday, January 10th. The stock was sold at an average price of $42.83, for a total transaction of $513,960.00. Following the sale, the senior vice president now owns 151,182 shares of the company's stock, valued at $6,475,125.06. The trade was a 7.35 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 2.80% of the stock is owned by insiders.
Genpact Profile
(
Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Recommended Stories

Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report